Citaloparam in migraine prophylaxsis

Phase 2

• Conditions: Condition 1: Migraine headaches. Condition 2: Migraine headaches.; Migraine without aura (common migraine; Migraine with aura (classic migraine)

• Registration Number: IRCT20161103030680N9
• Lead Sponsor: Shahed University

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 26 March 2018

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 226

Inclusion Criteria

Age between 18 to 45.
Suffering from migraine headaches according to international headache society criteria(IHS).
At least three attack of migraine in one month.
History of migraine for at least six months.

Exclusion Criteria

Suffering from another type of headaches such as Cluster,Tension,.... .
History of Asthma, Renal and Heart failure, Depression, any allergic reaction to drugs used in study or similar drugs.
Patients who already take drugs for treatment for migraine.
History of using anti depressant, anti epileptics, Analgesics, Corticosteroids, Opium, Monoamine Oxidase, and Non steroidal anti inflammatory agents for other reasons.

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Headache Intensity. Timepoint: At the beginning and at the end of first and second month. Method of measurement: Visual Analougue Scale, And Six points behavioral rating scale BRS-6.;Headache frequency. Timepoint: At the beginning and at the end of second month. Method of measurement: Number of attacks in one month.;Headache duration. Timepoint: At the beginning and at the end of second month. Method of measurement: Average of headaches duration in hour.

Secondary Outcome Measures

Name	Time	Method
Drug reactions such as skin redness, pruritus, burning sensation,. Timepoint: Immediately after patient alarm. Method of measurement: Observation and consultation with proper specialist.